Stock search

Ticker or company name

CRL card

CRL price forecast

Charles River Laboratories$335,52

P/E now is 345,9. Average over 5 years: 100,9 (range 23–29). The stock is 243% above its history.

Base · FY2030

$742,47+21,3% a year

The base case gives 21,3% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$4,28 bn$4,56 bn$4,86 bn$5,18 bn$5,51 bn
Net income$277 m$295 m$314 m$335 m$357 m
EPS$5,61$6,00$6,42$6,87$7,36

Changed values are highlighted. Bear and bull cases: growth ∓ 9,7%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $335,52

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$73,01

Price change
−78,2%
A year
−31,0%
Fair value today
$49,36
Margin of safety
−85,3%

Base$742,47

Price change
+121,3%
A year
+21,3%
Fair value today
$501,90
Margin of safety
+49,6%

Bull$437,87

Price change
+30,5%
A year
+6,7%
Fair value today
$295,99
Margin of safety
−11,8%

What growth the price implies

For the stock to return 10% a year, revenue must grow −1,7% a year to FY2030 at a 6,5% margin and P/E 100,9.

Growth over 5 years
6,5%
Analyst consensus
no data
In your model
6,5%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$742,47+21,3% a year